Gary D. Glick

2 ta ish

Ifm Therapeutics (United States)

1. Dimers of mitochondrial ATP synthase form the permeability transition pore

   Valentina Giorgio, Sophia von Stockum, Manuela Antoniel +9

   MaqolaOAOchiq kirish20132 iqtibos

   ABIABI:AkademIndex/2026.other.062873

2. Targeting the NLRP3 inflammasome in inflammatory diseases

   Matthew Mangan, Edward J. Olhava, William Roush +3

   Sharh maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.443046